INVO Fertility, Inc. IVF
Medical/Dental Instruments · data as of November 13, 2026
INVO Fertility, Inc. (IVF) is a healthcare company listed in the US with a market value of about $3M. In the twelve months to June 30, 2026 it had revenue of $8M and net income of -$7M, a net margin of -92.3%.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -172%.
About INVO Fertility
INVO Fertility is listed in the US and classified in medical/dental instruments. Revenue went from $4M in 2021 to $7M in 2025, growth of about 13.2% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 31128% over three years (dilution for shareholders).
Score: 0.4 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $8M | $7M | $7M | $3M | $822196 | $4M |
| Net income | -$7M | -$23M | -$9M | -$8M | -$11M | -$7M |
| Free cash flow | -$5M | -$7M | -$3M | -$5M | -$7M | -$6M |
| EPS (diluted) | $430.35 | $-214.64 | $-3782.65 | $-8295.00 | $-29051.39 | $-20369.94 |
| Net margin | -92.3% | -340.9% | -141.8% | -266.0% | -1324.8% | -160.0% |
| ROIC | — | -66.3% | -24.2% | -74.3% | -649.4% | -43.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does INVO Fertility pay a dividend?
Not currently.
Is INVO Fertility a good stock to buy?
We do not give buy or sell advice. INVO Fertility scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.